KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Ionis Pharmaceuticals (IONS) Asset Utilization Ratio (2016 - 2025)

Historic Asset Utilization Ratio for Ionis Pharmaceuticals (IONS) over the last 16 years, with Q3 2025 value amounting to 0.26.

  • Ionis Pharmaceuticals' Asset Utilization Ratio fell 530.07% to 0.26 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.26, marking a year-over-year decrease of 530.07%. This contributed to the annual value of 0.24 for FY2024, which is 1749.25% down from last year.
  • As of Q3 2025, Ionis Pharmaceuticals' Asset Utilization Ratio stood at 0.26, which was down 530.07% from 0.27 recorded in Q2 2025.
  • Ionis Pharmaceuticals' Asset Utilization Ratio's 5-year high stood at 0.36 during Q3 2022, with a 5-year trough of 0.14 in Q1 2021.
  • In the last 5 years, Ionis Pharmaceuticals' Asset Utilization Ratio had a median value of 0.26 in 2025 and averaged 0.25.
  • In the last 5 years, Ionis Pharmaceuticals' Asset Utilization Ratio skyrocketed by 16356.99% in 2021 and then tumbled by 4196.72% in 2023.
  • Ionis Pharmaceuticals' Asset Utilization Ratio (Quarter) stood at 0.32 in 2021, then dropped by 26.49% to 0.24 in 2022, then rose by 12.18% to 0.27 in 2023, then dropped by 12.84% to 0.23 in 2024, then increased by 13.69% to 0.26 in 2025.
  • Its Asset Utilization Ratio stands at 0.26 for Q3 2025, versus 0.27 for Q2 2025 and 0.25 for Q1 2025.